MMP2 and breast carcinoma: Besides, Bostanci et al stated that inhibiting the expression of SLC30A2 expression could decrease the invasive capacity of MDA-MB-453 breast cancer cells by downregulating the matrix metalloproteinase 2 (MMP-2) expression 10.